Price To Earnings Ratio -192.92 | Sector PE 64.54 |
PB Ratio 6.42 | Sector PB 8.75 |
EPS -7.68 | Dividend Yield 0.32 |
Today's Volume 383.478 K | 5 Day Avg. Volume 332.002 K |
PEG Ratio -2.93 | Market Cap. ₹ 13,010.00 Cr. |
Time | STAR | VS | Industry |
---|---|---|---|
1 Day | 6.62% | -0.45% | |
1 Week | 2.7% | -2.17% | |
1 Month | -8.92% | -5.44% | |
6 Months | 53.76% | 13.28% | |
1 Year | 205.07% | 45.18% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 1444.33 | Bullish |
20 | 1477.47 | Bullish |
30 | 1504.66 | Bearish |
50 | 1446.39 | Bullish |
100 | 1309.91 | Bullish |
200 | 1126.79 | Bullish |
Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |||||
---|---|---|---|---|---|---|---|---|---|
Operating Activities | 701.07 | 44.41 | -257.81 | 481.44 | |||||
Investing Activities | -150.25 | 302.47 | -118.73 | -520.82 | |||||
Financing Activities | -693.32 | -213.92 | 421.32 | -15.80 | |||||
Net Cash Flow | -142.51 | 132.96 | 44.77 | -55.18 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
Strides Pharma Science | 6.62 | 2.7 | -8.92 | 53.76 | 205.07 |
Alembic | -1.78 | -8.08 | -1 | -8.08 | -8.08 |
Aurobindo Pharma | -2.33 | -3.54 | -15.93 | -9.27 | 21.14 |
Fortis Healthcare | 3.49 | 4.8 | 11.69 | 34.92 | 85.6 |
Ajanta Pharmaceuticals | -0.46 | 3.53 | -6.26 | 10.84 | 44.01 |
Strides Pharma Science Limited is an Indian pharmaceutical company. The company focuses on the development and production of IP-based niche and pharmaceutical products. It operates in two segments: Pharmaceuticals and Biopharmaceuticals. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India and others. The company manufactures a variety of niche and pharmaceutical products, including various dosage forms such as liquids, ointments and creams, soft gels, sachets, tablets and controlled dosage forms. It has eight manufacturing facilities in India (Bengaluru, Puducherry and Chennai), Singapore, Italy (Milan), USA (Florida) and Kenya (Nairobi). It also makes soft gelatin capsules. It develops and manufactures drugs for the antiretroviral, antimalarial, tuberculosis, hepatitis and other infectious disease drug segments for its institutional business.